Novacyt S.A. (ALNOV.PA) Stock Price
€0.467 2%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novacyt S.A., AI stock picks, stock alerts and much more.
ALNOV.PA AI Stock Analysis
AI stock analysis for ALNOV.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novacyt S.A. (ALNOV.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Novacyt S.A. (ALNOV.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novacyt S.A. (ALNOV.PA), currently trading at €0.467, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALNOV.PA
-
Novacyt S.
-
Symbol
ALNOV.PA
-
Market
EURONEXT
-
Industry
Medical - Devices
-
Market Cap
33M
Similar Stocks
 |
Euroapi S.A. EAPI.PA |
€2.76 2.2% |
5 |
 |
Euromedis Groupe ALEMG.PA |
€3.95 0.9% |
5 |
 |
Median Technologies SA ALMDT.PA |
€2.27 1.1% |
3 |
 |
Diagnostic Medical Systems S.A. ALDMS.PA |
€1.06 6.9% |
4 |
 |
Ion Beam Applications SA IBAB.BR |
€11.56 1.6% |
4 |
News
ALNOV.PA Alternative Data
Web Traffic
Novacyt S.A. receives an estimated 3529 monthly visitors to novacyt.com, which is up by 10.7% over the last month.
-
Web Traffic
3529
-
Change from Previous Month
10.7%
-
3 Month Change
58.1%
-
YoY Change
58.1%
Twitter Followers
Novacyt S.A. has 2,780 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.
-
Twitter Followers
2780
-
Daily Change
0.2%
-
1 Month Change
0.4%
-
3 Month Change
1.1%
Facebook Engagement
Novacyt S.A. has engaged 5 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
5
-
Daily Change
16.7%
-
1 Month Change
0%
-
3 Month Change
0%
Youtube Subscribers
Novacyt S.A. has 685 subscribers on its main Youtube channel, down by -0.3% over the last month.
-
Youtube Subscribers
685
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.4%
Job Postings
Novacyt S.A. currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Novacyt S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
7,730 are following Novacyt S.A. on LinkedIn, up by 0.1% over the last month.
-
LinkedIn Followers
7730
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.9%
LinkedIn Employees
According to LinkedIn, Novacyt S.A. has 68 employees.
-
LinkedIn Employees
68
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
8.1%
Reddit Mentions
Novacyt S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Novacyt S.A. is 29 out of 100 (bearish).
-
Business Outlook
29
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
ALNOV.PA Financials
ALNOV.PA Key Metrics
-
Total Revenue
€9.6M
-
Net Income
€0
-
Earnings per Share
€0
-
Free cash flow
-€4.9M
-
EBITDA
€9.6M
-
EBITDA Ratio
1
-
Total Assets
€133.8M
ALNOV.PA 2-year Revenue & Income
ALNOV.PA 2-year Free Cash Flow
ALNOV.PA Technicals
ALNOV.PA SMA
ALNOV.PA RSI
FAQ
What's the current price of Novacyt S.A. (ALNOV.PA) Stock?
The price of an Novacyt S.A. (ALNOV.PA) share is €0.467.
What's the market cap of Novacyt S.A.?
The current market cap of Novacyt S.A. is 33M.
Should I buy or sell ALNOV.PA?
Novacyt S.A. shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novacyt S.A. is better viewed as a hold or accumulate position while waiting for further developments.
Is Novacyt S.A. a good investment?
The current analysis of Novacyt S.A.'s fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novacyt S.A.'s portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Novacyt S.A. (ALNOV.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novacyt S.A. stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Novacyt S.A. (ALNOV.PA) that investors often compare it to?
Novacyt S.A. (ALNOV.PA) is often compared to similar stocks such as Euroapi S.A., Euromedis Groupe, Median Technologies SA, Diagnostic Medical Systems S.A. and Ion Beam Applications SA.
What is the forecast for Novacyt S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novacyt S.A.'s stock price to be around €0.447 in 2026. Starting from the current price of €0.467, this represents a 4.3% change in price, indicating a bearish outlook for the stock.
How to buy Novacyt S.A. (ALNOV.PA) Stock?
Novacyt S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novacyt S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.